State Street SPDR S&P Biotech ETF (XBI) News
Track canonical SquawkNews coverage tagged to XBI, State Street SPDR S&P Biotech ETF. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
XBI +1.5% around $154 level, as Biotech a Bright spot today (down from recent record highs $165.71)
XBI +1.5% around $154 level, as Biotech a Bright spot today (down from recent record highs $165.71)
EQUITY | Jul 17, 2026, 07:43 PM UTC
L
XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approval
XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approvals, STAT News reported. It’s starting with a small number of markets selected alo
REGULATION | Jul 16, 2026, 12:12 PM UTC
L
XBI ETF near highs
XBI ETF is trading near its highs
EQUITY | Jun 25, 2026, 02:59 PM UTC